1492PAssessing the impact of subsequent checkpoint inhibitor (CPI) treatment on overall survival: Post hoc analyses from the phase III JAVELIN Lung 200 study of avelumab vs docetaxel in platinum-treated locally advanced/metastatic non-small cell lung cancer (NSCLC)
Barlesi, F, Özgüroğlu, M, Vansteenkiste, J F, Spigel, D, Yang, J C-H, Bajars, M, Ruisi, M, Manitz, J, Park, KVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz260.014
Date:
October, 2019
Fichier:
PDF, 105 KB
2019
File converter
Plus de résultats de recherche
More benefits 
